NCT00985036

Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients

Is VEGF a Useful Serum Biomarker for Patients Diagnosed With Meningioma or Glioma?

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: Marquette General Health System · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

Objectives: This study is looking at the level of vascular endothelial growth factor (VEGF) circulating in the blood stream of patients diagnosed with either a meningioma or a glioma. The questions that will be addressed include: 1. Can VEGF level alert us to tumor progression or recurrence before MRI changes occur? 2. Is the VEGF level an indicator of the response to treatment? 3. Does the VEGF level correlate with tumor histology and behavior? 4. Is there a relationship between VEGF level and outcome?

Conditions

• Glioma
• Meningioma

Interventions

Type	Name	Description
PROCEDURE	Blood test	an additional vial of blood will be obtained at the time of MRI or at the time of routine blood tests ordered by the medical oncologist. In other words, there will be no extra needle sticks. Just an extra vial of blood will be taken during a routine blood test

Timeline

• Start date: 2009-09-01
• Primary completion: 2011-09-01
• Completion: 2012-01-01
• First posted: 2009-09-28
• Last updated: 2012-04-24

Locations

1 site across 1 country: United States